Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
4 clinical trials · Condition
◉ Watch Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
| Record | Firm | Date |
|---|---|---|
| Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma (NCT05449483) | Tianjin Medical University Cancer Institute and Hospital | 2022-05-11 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer (NCT04006041) | Jianhua Fu | 2019-06-25 |
Track Esophageal Squamous Cell Carcinoma by AJCC V8 Stage automatically
Every clearance here is in the API, with alerts when new ones post.